凯发k8国际首页登录

News Center

First Patient Enrolled in China for Phase Ⅱ Clinical Trial of Luye Pharma’s Class 1 Inno...

2025-01-16 MORE>
Boan Reached a Strategic Cooperation for Denosumab in Brazil

2024-11-27 MORE>
First Patient Dosed in Phase 1 Study of Boan’s CD228 ADC

2024-11-20 MORE>
Luye Pharma’s Class 1 Innovative Antidepressant Targeting NET/DAT/GABAAR Approved for Cli...

2024-11-20 MORE>
Luye Pharma Announces 2024 Half Year Results

2024-08-29 MORE>
Boan Biotech Announces 2024 Half Year Results: Revenue Grows by 39%, Net Profit Increases ...

2024-08-28 MORE>

Total:130 / Page:22 First Prev 1 2 3 4 5 Next Last

LUYE All Rights Reserved Privacy policy Terms of use

TOP

<tr id='lmKCw'><strong id='wPl0n'></strong><small id='g1Ab5'></small><button id='GUEye'></button><li id='SrS6k'><noscript id='XRUzC'><big id='lhgtB'></big><dt id='l1A1p'></dt></noscript></li></tr><ol id='AGTCE'><option id='9afKF'><table id='spmgi'><blockquote id='4DPsI'><tbody id='P6VHc'></tbody></blockquote></table></option></ol><u id='0ThKT'></u><kbd id='QuOiO'><kbd id='mIpBl'></kbd></kbd>

<code id='Ae8Tt'><strong id='1ohN7'></strong></code>

<fieldset id='nojq5'></fieldset>

<span id='eWXoJ'></span>

<ins id='0BseY'></ins>

<acronym id='M5LY4'><em id='tGV23'></em><td id='c8ViZ'><div id='X8z7u'></div></td></acronym><address id='QvCWd'><big id='yeglE'><big id='iASzO'></big><legend id='TGJtS'></legend></big></address>

<i id='zDy5R'><div id='q0cZ4'><ins id='7Nsw0'></ins></div></i>

<i id='eIoWX'></i>